Recombinant human granulocyte stimulating factor (CSPC Pharma)

重组人粒细胞刺激因子（石药集团）

Report date: 2025/01/07 14:46:49

Base Information

Drug NameRecombinant human granulocyte stimulating factor (CSPC Pharma)
Drug Alias Name非格司亭生物类似药（石药集团）Filgrastim (CSPC Pharma)非格司亭生物仿制药（石药集团）津恤力GeneLeukim
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaNeutropenia
Original Approved Country/TerritoryMainland China
Original Approved Date2000/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesCSPC Pharmaceutical Group Ltd
China Registration ClassN/A

Develop Information

Active CompaniesCspc Baike (Shandong) Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA02
Related LinksN/A